U.S., Dec. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07263711) titled 'Prospective Real-World Study of Pathology AI for Glioma Molecular Prediction' on Nov. 13.
Brief Summary: The goal of this clinical study is to learn if an artificial intelligence (AI) model can accurately predict important molecular changes in gliomas, a type of brain tumor, using digital pathology images.
The main questions this study aims to answer are:
How accurate is the AI model in predicting key molecular alterations compared with standard molecular testing? Can the AI model shorten the time needed for diagnosis and reduce the need for expensive molecular tests?
Researchers will collect whole slide images from multiple hospi...